Files in This Item:


Title: Sickle-Cell Disease in the African Region: Current Situation and the Way Forward Report of the Regional Director
Authors: Regional Committee for Africa, 56
Issue Date: 2006
Publisher: WHO. Regional Office for Africa
Place of publication: Brazzaville
Language: English
Abstract: Sickle-cell disease is a genetic blood disorder that affects the haemoglobin within the red blood cells. The recurrent pain and complications caused by the disease can interfere with many aspects of the patient’s life, including education, employment and psychosocial development. Neonatal screening for the sickle-cell trait, when linked to timely diagnostic testing, parental education and comprehensive care, can markedly reduce morbidity and mortality from the disease in infancy and early childhood. 2. In most of the countries where sickle-cell disease is a major public health concern, national programmes for its control do not exist. Basic facilities to manage patients are usually absent, systematic screening for sickle-cell disease is not common practice and the diagnosis of the disease is usually made when a severe complication occurs. As a result, more than 50% of the children with the most severe form of the disease die before the age of five, usually from an infection or severe anaemia.
Description: Regional Committee for Africa Fifty-sixth Session Addis Ababa, Ethiopia, 28 August–1 September 2006, Provisional agenda item 8.11
Subject: Sickle Cell Trait
Genetic Diseases, Inborn
Blood Cells
Pain Perception
Neonatal Screening
Health Status
Regional Health Planning
Gov't Doc #: AFR-RC56-17
Appears in Collections:Regional Committee for Africa

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.